BPCL Partners with KPIT Technologies to Enhance Hydrogen-Based Mobility in Keralac) BPCL Launches Emerge Cohort under BPCL Ankur Fund to Foster Innovation in EnergyEfficiency and City Gas Distribution ...

Overview: Topical urea is used for a variety of skin conditions, usually involving thick, dry, or itchy skin. It may work by adding moisture, softening the area, or helping your body shed dead ...

What do Litmus meetings aim for? Fact-based politics is one. Politics now is completely based on lies, claims, and counterclaims. Nothing to do with facts. One leader recently said in court: “We ...

Sharad Pawar’s attempt to blame states for price rise has backfired. States say the onus is on the Centre to abandon its ‘faulty’ policies. DNA Web Team Updated : Nov 19, 2013, 11:17 PM IST Kerala C ...

Bradley Pharmaceuticals 2006 Results - read this article along with other careers information, tips and advice on BioSpace ...

Keralac(TM) NAILSTIK (50% urea) and Keralac(TM) OINTMENT (50% urea) have been added to the Keralac(TM) line of Urea-based keratolytics; ADOXA(R) Pak(TM) 1/75mg, a new convenient pack, and ADOXA(R) Pak ...

Bradley is facing earlier-than-expected generic competition to its Keralac moisturizer product. In a report released Tuesday, Banc of America Securities said the Keralac issue "highlights one of ...

In other news, shares of Bradley Pharmaceuticals sank after investment bank Raymond James warned that sales of the company's prescription skin softener Keralac could be hurt by an earlier-than ...

Analyst Michael Krensavage noted that Keralac was launched in July, but has already become Bradley's second-largest brand. He added that Bradley had hoped that a patent pending would delay generics.

Wachovia analyst Michael Tong downgraded the stock to "market perform" from "outperform," due to earlier than expected generic competition for the company's prescription skin softener, Keralac.